FDA warns Globus Medical over Excelsius GPS robot-related misplaced screw complaints and late or missing device reports.
What happened
FDA inspected the firm from February 15, 2024, through March 7, 2024, and found quality-system violations. It found repeated misplaced-screw complaints for the Excelsius GPS surgical robot were not properly analyzed for corrective action, and complaint investigations were inadequate, including one involving a patient death. FDA also found Medical Device Reporting (MDR) reports were late, misclassified, or missing, and electronic acknowledgments were not maintained.
What FDA found
FDA found the company did not start corrective and preventive action (CAPA) investigations when complaints showed repeated misplaced screws, and its trend analysis lacked appropriate statistics and risk evaluation.
21 CFR 820.100(a)(1)FDA found complaint investigations were not comprehensive, including a patient death complaint and a missed pedicle screw complaint.
21 CFR 820.198(c)FDA says a serious injury from damage to the spinal cord’s dural lining was reported late and incorrectly classified as a malfunction.
21 CFR 803.50(a)(1)FDA says several complaints about misplaced screws were reportable malfunctions, but the reports were late or not received.
21 CFR 803.50(a)(2)FDA found the company could not provide FDA electronic acknowledgments for several MDR submissions.
21 CFR 803.18(b)(1)(iii)
What FDA wants
FDA asks the company to notify it in writing within 15 business days of steps taken, planned corrections, documentation, and a timetable for any work that will take longer.
Who should pay attention
- hospitals and surgeons using the Excelsius GPS surgical robot
- medical device makers with complaint-handling and MDR reporting duties
- quality teams that use complaint trends to decide on CAPA
This is a summary. Read the original letter on fda.gov.